Search Results

You are looking at 91 - 100 of 1,029 items for :

  • "community" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Rapid Access to Mental Health Professionals With Experience in Treating Cancer-Related Distress: The American Psychosocial Oncology Referral Helpline

Elizabeth Harvey, Lauren Rogak, Ruth Ford, and Jimmie Holland

of psychologists, social workers, nurses, counselors, and psychiatrists, it has maintained a helpline (1-866-276-7443) since 2003 to help patients find a counselor in their local community through a directory maintained by the society. This can serve

Full access

Ovarian Cancer Guidelines: Treatment Progress and Controversies

Robert J. Morgan Jr.

therapeutic developments. Nonetheless, significant controversies remain, and these controversies can cause major disagreement among experts. This issue of JNCCN proves this point and also illustrates the importance that we in the medical community must place

Full access

Benefits Associated with an Early Hemoglobin Response to Epoetin Alfa Therapy in the Treatment of Chemotherapy-Related Anemia

Susana M. Campos, Mei Sheng Duh, Patrick Lefebvre, and James Rosberg

disease response or tumor type: results from a prospective community oncology study. Procrit Study Group . J Clin Oncol 1998 ; 16 : 3412 – 3425 . 10 Gabrilove JL Cleeland CS Livingston RB . Clinical evaluation of once-weekly dosing of

Full access

Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020

Leigh Gallo, Ronald S. Walters, Jeff Allen, Jenny Ahlstrom, Clay Alspach, Yelak Biru, Alyssa Schatz, Kara Martin, and Robert W. Carlson

–agnostic approvals that were based on common genetic alterations rather than the tissue of origin. The OCE coordinated work across the various medical product centers throughout the FDA, and with the cancer research community, to make these advancements possible

Full access

NCCN Policy Summit: Cancer Care in the Workplace: Building a 21st Century Workplace for Patients, Survivors, and Caretakers

Victoria Hood, Lindsey Bandini, Taneal Carter, Alyssa Schatz, John Sweetenham, Warren Smedley, Joanna Fawzy Morales, Rebecca V. Nellis, Randy A. Jones, Lynn Zonakis, and Robert W. Carlson

Community, agreed that navigation and support are critical, because benefits are often difficult for individuals to understand and navigate. Panelists also emphasized the importance of considering long-term rather than just short-term costs when

Full access

Neutrophil Biology and the Next Generation of Myeloid Growth Factors

David C. Dale

candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors . Transfusion 2002 ; 42 : 1414 – 1421 . 57 Ofran Y Avivi I Oliven A . Granulocyte transfusions for

Full access

Are NCI Cancer Centers Providing Adolescents and Young Adults With Cancer Focused Clinical Services? A National Survey

Katherine Daunov, Michael Daunov, Kara Noskoff, Hilary Gan, Simon Davies, Megan Farrell, Whitney Hadley, Amelia Baffa, Jennifer Giesel, Rachel Egler, Alex Y. Huang, John J. Letterio, and Richard T. Lee

centers (7%) offered referral to a community fertility clinic not affiliated with their center. Most (78%) provided services if requested by patients. To a lesser extent, respondents reported sexual health being addressed in the survivorship phase (47%) or

Full access

How Have Multigene Panels Changed the Clinical Practice of Genetic Counseling and Testing

Robert Pilarski

and counseling. 28 Community Education Although panel testing has certainly moved clinical practice forward in many ways, it has also introduced its own set of problems that highlight the need for education of community practitioners on the

Full access

QIM19-142: Development of a Low Resource Tool for Improving Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System

Vlad Sandulache, Anita Sabichi, George Chen, and Scott Charnitsky

designed to streamline cancer diagnosis and treatment. Head and neck cancer (HNC) remains a difficult disease to diagnose and treat. Delivery of multimodality treatment for advanced HNC is challenging at both academic centers and in the community setting

Full access

HSR19-084: Real-World Treatment Patterns and Clinical Outcomes in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations

Maral DerSarkissian, Shuanglian Li, Aaron Galaznik, Rachel Bhak, Iryna Bocharova, Thomas Kulalert, Huamao M. Lin, Hui Huang, and Mei Sheng Duh

: Flatiron Health electronic health record data, largely from community oncology practices, from January 2011–April 2018 were used for this retrospective observational study. Treatment-naïve (TN) and relapsed/refractory (RR) second-line patients diagnosed